Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China · Delayed Price · Currency is CNY 30.86
+0.46 (1.51%)
Sep 30, 2026, 3:00 PM CST
SHA:603983 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,358 | 3,459 | 2,970 | 2,226 | 1,732 | 1,787 |
Revenue Growth | -0.72% | 16.48% | 33.44% | 28.52% | -3.09% | 2.41% |
Gross Profit Gross Profit Growth | 2,474 | 2,567 | 2,177 | 1,560 | 1,175 | 1,133 |
Operating Income Operating Income Growth | 134.15 | 231.39 | 339.26 | 175.31 | 137.59 | 216.34 |
Net Income Net Income Growth | 228.3 | 247.24 | 341.63 | 259.42 | 174.18 | 247.92 |
Earnings Per Share EPS Growth | 0.58 | 0.62 | 0.85 | 0.65 | 0.43 | 0.62 |
EPS Growth | -31.25% | -27.06% | 30.77% | 51.16% | -30.64% | -46.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,866 | 1,793 | 2,472 | 2,124 | 1,844 | 1,659 |
Total Debt Total Debt Growth | 409.42 | 397.81 | 793.97 | 255.48 | 270.44 | 19.47 |
Net Cash (Debt) Net Cash Growth | 1,457 | 1,396 | 1,678 | 1,869 | 1,574 | 1,640 |
Net Cash Growth | 0.45% | -16.82% | -10.22% | 18.75% | -4.03% | -31.21% |
Net Cash Per Share Net Cash Per Share Growth | 3.69 | 3.50 | 4.17 | 4.68 | 3.89 | 4.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 173.44 | 273.88 | 300.53 | 338.02 | 48.44 | -7.48 |
Capital Expenditures CapEx Growth | -189.22 | -205.25 | -316.37 | -254.05 | -110.91 | -117.14 |
Free Cash Flow Free Cash Flow Growth | -15.79 | 68.63 | -15.85 | 83.98 | -62.47 | -124.62 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.68% | 74.19% | 73.29% | 70.11% | 67.83% | 63.38% |
Operating Margin | 4.00% | 6.69% | 11.42% | 7.88% | 7.95% | 12.11% |
Pretax Margin | 7.44% | 8.55% | 12.82% | 14.25% | 11.93% | 17.33% |
Profit Margin | 6.80% | 7.15% | 11.50% | 11.66% | 10.06% | 13.87% |
FCF Margin | -0.47% | 1.98% | -0.53% | 3.77% | -3.61% | -6.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.750 | 0.520 | 0.250 | 0.190 |
Dividend Per Share Growth | -33.33% | -33.33% | 44.23% | 108.00% | 31.58% | -45.71% |
Dividend Yield | 1.62% | 1.52% | 2.39% | 2.17% | 0.79% | 0.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 53.43 | 53.77 | 37.87 | 39.06 | 77.76 | 51.65 |
Forward PE | 38.81 | 27.36 | 29.69 | 30.89 | 45.45 | 34.27 |
P/FCF Ratio | - | 193.70 | - | 120.67 | - | - |
PS Ratio | 3.69 | 3.84 | 4.36 | 4.55 | 7.82 | 7.17 |